Sign in
TerminatedNo phase

Wearable Auscultation Device Validation in Children

Key facts

Who runs it
Strados Labs, Inc.
Where
Chicago, United StatesSee the site
Trial code
Status
Terminated
People taking part
36 people enrolled
Started
7 Aug 2023
Ended
24 Jun 2024
Type of study
Observational, 2 groups
Treatments tested
  • RESP™ Biosensor
Record updated
5 July 2024
Why it stopped
The Principal Investigator is departing from the study site.

Who can take part

Age
4 years to 17 years
Sex
Women and men

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Any child aged 4-17 years of age
  • Admitted to Lurie Children's Hospital or the Emergency Department at Lurie
  • Normal breath sounds cohort: (16 patients ages 4-10, 16 patients ages 11-17); Admitted for a non-respiratory complaint; Normal breath sounds on screening examination
  • Wheeze cohort: (53 patients ages 4-10, 53 patients ages 11-17); Admitted for pathologic process that may lead to wheezing (e.g., asthma); Presence of wheeze on screening examination

Who cannot take part

  • Unstable disease posing a threat to life
  • Adhesive allergy
  • Children less than age 4, adults (age 18 and above)
  • Patients in the ambulatory setting
  • Unable to provide consent
  • Intubated patients

Where in United States

  • Lurie Children's Hospital of ChicagoChicago, United States

About the trial

What the trial wants to find out

This observational clinical study is an evaluation of a diagnostic tool through comparison. Similar to a validation study, the output of the RESP device will be compared to physician auscultation, surrogated by having an attending pulmonologist listen to blinded recordings.

The 2 groups in the trial

  • Normal Breath Sound Cohort

    32 patients ages 4-10, 16 patients ages 11-17) * Admitted for a non-respiratory complaint * Normal breath sounds on screening examination

    Treatment: RESP™ Biosensor

  • Wheeze Cohort

    (106 patients ages 4-10, 53 patients ages 11-17) * Admitted for pathologic process that may lead to wheezing (e.g., asthma) * Presence of wheeze on screening examination

    Treatment: RESP™ Biosensor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
5 July 2024